This collective reflection aims to examine current mandatory detention policies which have proved inefficient, and call governments to refocus on health and social justice.
The concept of ‘alternative development’ has dominated the intersection of drug control and development historically – but has been subject to growing critique. We explore how can it evolve into meaningful promotion of sustainable livelihoods for impacted communities, including possibilities for transitioning into legally regulated drug crop products.
EHRN will confront the question of how best to engage with both decision makers and the public who hold them to account, in order to promote an ethical rationalisation of drug policy.
EHRN will apply 5 different approaches to decriminalization in 5 countries and discuss their impact on the lives of people who use psychoactive substances and society at large.
In this EHRN session, dedicated experts in the fields of harm reduction and drug policy will review and discuss the specific challenges therein, as laid out in the Harm Reduction Journal.
Correlation-EuroHRN hosts a series of seminars on subjects such as COVID-19's effects on harm reduction efforts for people who use drugs, different approaches to decriminalisation, and more ethical drug policies.
In this EHRN webinar, the lessons learnt from COVID-19 and the way forward in responding to the pandemic will be examined from diverse group of perspectives.
The fifth European Harm Reduction Conference will assess the impacts of harm reduction and drug policy on people who use drugs, sex workers, and people living with HIV.
Webinar outlining how opioid stigma reduction programs can measure the behaviours of first responders and health-care providers towards people living with opioid use.
The event will feature Tlaleng Mofokeng, UN Special Rapporteur on the Right to Health, alongside harm reduction and human rights experts from around the world.